Memorial Cancer Institute
- Cancer Institute Home
- About Us
- Disease-Specific Programs
- Health Library
- Medical Oncology/Hematology
- Meet the Physicians
- Newsletter
- Radiation Oncology
- Surgical Oncology
- Gynecologic Oncology
- Clinical Research
- Hereditary Cancer / Genetics Program
- Support Services
- The Image Recovery Center®
- Testimonials
- Online Cancer Resources
- Contact Us
Hereditary Cancer / Genetics Program
Memorial Cancer Institute is a leading-edge facility for cancer diagnosis and treatment, and one of a few facilities in the nation with an oncology geneticist on staff. Led by Elisabeth McKeen, MD, Memorial Cancer Institute’s genetics program focuses on the nature of hereditary influences on other cancers.
Memorial Cancer Institute offers genetic testing, counseling and participation in clinical protocols not only to diagnosed cancer patients but also to any family member who would like to ascertain their genetic predisposition for cancer. These counseling sessions provide people with reports containing personalized genetic information and advice pertaining to lifestyle and dietary modifications that can minimize their cancer risk.
Memorial emphasizes the prevention of cancer by identifying high-risk individuals. By coordinating information with primary care physicians, gynecologists and other specialists, the genetics program helps foster preventive measures and early detection for these patients.
Disease-Specific Programs
Memorial Cancer Institute takes a special interest in studying the genetic factors that may contribute to breast, colorectal, gynecological and melanoma cancers.
- Breast Cancer/Gynecological Cancer
Current research efforts focus on the mutations in BRCA1 and BRCA2, the genes that account for approximately 10 percent of all breast cancer cases. Through a grant from the Susan G. Komen Foundation, Memorial Cancer Institute is able to provide free genetic testing and counseling to uninsured patients. - Colorectal Cancer
Current research efforts focus on the mutations of the MLH1, MSH2 and MSH6 genes, as well as the genes that lead to familial adenomatous polyposis (FAP). - Melanoma
Current research efforts focus on the mutation of the P16 gene and the link between melanoma and pancreatic cancer.